Juvenile Psoriatic Arthritis is popular now. Below, you'll find the most up to date information. Continue for the latest news and searches whether on or off Arthritis Pain Products. See any links under "Main Menu" for general information about Arthritis Pain Relief.
A friend of mine thought she broke her finger. It had swollen up and was painful to the touch.
We talked to someone known as an expert regarding this and it turns out the finger was not broken. It had calcium deposits on the joints... the early signs of arthritis.
In fact, as he checked her fingers it turns out that
Read more ...
Arthritis And Diet Arthritis can be helped by paying attention to your diet. Today lets take a look at minerals and the role they play in bone, ligament and cartilage health.MINERALS NEEDED IN THE DIET:Boron - This trace mineral aids in bone health.Calcium - This is a much-needed mineral for bone health.Magnesium - Magnesium helps keep calcium in balance within the
Read more ...
Thinking about exercise and arthritis? It is not uncommon for
people to show their horror at this thought. For many years it
was believed that arthritis and exercise doesn't go hand in
hand. However a recent study has revealed that exercise can in
fact help people with arthritis. Additionally exercise is
becoming a vital tool in managing arthritis.
Regular exercise helps in improving the flexibility of
Read more ...
Still didn't find what you need then try these common Juvenile Psoriatic Arthritis news items.
-
Protalix Announces New Clinical Data on Taliglucerase Alfa to be Presented at the WORLD Lysosomal Disease Network ...
CARMIEL, Israel -- Protalix BioTherapeutics, Inc. (NYSE Amex:PLX) , announced today that new clinical data on taliglucerase alfa will be presented at the 8th Annual Meeting of the Lysosomal Disease Network: ...
Wed, 25 Jan 2012 23:00:00 -0800
EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC
MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6 ...
Sat, 21 Jan 2012 00:39:52 -0800